In a patient on chlorpromazine with mildly elevated BUN but normal creatinine, what is the significance of an AST of 21 U/L and ALT of 16 U/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

These liver enzyme values are completely normal and reassuring

AST 21 U/L and ALT 16 U/L are well within normal reference ranges and do not suggest any hepatotoxicity from chlorpromazine. These values are actually quite low and provide no evidence of drug-induced liver injury (DILI).

Context and Interpretation

Normal ALT reference ranges are approximately 19-33 U/L for men and 19-25 U/L for women 1. Your values fall comfortably within these limits. The chlorpromazine FDA label 2 specifically warns about monitoring for jaundice and liver dysfunction, but your transaminases show no elevation whatsoever.

Key Clinical Points:

  • No DILI signal present: Guidelines define DILI thresholds starting at ALT ≥3× ULN (upper limit of normal) with symptoms, or ≥5× ULN without symptoms 3. Your ALT of 16 U/L is nowhere near these thresholds.

  • AST/ALT ratio is normal: Your AST/ALT ratio is approximately 1.3, which is within the expected range. Ratios >2 typically suggest alcohol-related liver disease, while ratios <1 suggest metabolic liver disease 1. Your ratio indicates neither.

  • The mildly elevated BUN with normal creatinine is unrelated to these normal liver enzymes. This pattern typically reflects prerenal azotemia (dehydration, decreased renal perfusion) rather than intrinsic renal or hepatic pathology.

Chlorpromazine-Specific Considerations

The FDA label 2 notes that chlorpromazine-induced jaundice typically occurs between weeks 2-4 of therapy and presents with laboratory features of obstructive jaundice. Your normal transaminases effectively rule out clinically significant hepatotoxicity. The label recommends liver function testing if fever with flu-like symptoms develops, but prophylactic monitoring with these normal baseline values is not mandated.

What to Monitor Going Forward:

  • Watch for clinical symptoms: fever, right upper quadrant pain, severe fatigue, nausea, or jaundice 3
  • If symptoms develop, repeat liver tests within 2-5 days
  • No routine monitoring is required with these normal baseline values unless symptoms emerge

Common Pitfall to Avoid

Do not confuse mildly elevated BUN with liver dysfunction. The BUN elevation likely reflects volume status or renal perfusion, not hepatic synthetic function. Bilirubin, INR, and albumin are better markers of hepatic function than transaminases alone 4.

Bottom line: Continue chlorpromazine without concern. These liver enzymes are normal and provide a reassuring baseline for future comparison should symptoms develop.

References

1
Guideline

acr appropriateness criteria® abnormal liver function tests.

Journal of the American College of Radiology, 2023

Related Questions

Is chlorpromazine appropriate for a patient with mildly elevated blood urea nitrogen and normal creatinine, and what dosing and monitoring are recommended?
What is the differential diagnosis for a 24-year-old woman with anxiety who presents with a normal lipid panel, mildly elevated aspartate aminotransferase (AST), normal alanine aminotransferase (ALT) at the upper limit of normal, normal fasting glucose, normal eosinophil count, leukopenia, mild anemia with microcytosis, and pruritus of the external ear canal?
In a 22-year-old African-American male with elevated alanine aminotransferase (ALT 141 U/L) and aspartate aminotransferase (AST 57 U/L), negative hepatitis serology, normal abdominal ultrasound, and mild anemia (hemoglobin 12.8 g/dL, hematocrit 40.5 %), what is the appropriate next step for evaluating the liver enzyme elevation—further work‑up or watchful waiting?
What is the appropriate diagnostic workup and treatment plan for a 30-year-old male with persistently elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), high hemoglobin and hematocrit, severe anxiety, and chronic gastrointestinal symptoms?
What is the interpretation of my lab results showing elevated Aspartate Aminotransferase (AST) and presence of ketones in urine?
Is chlorpromazine appropriate for a patient with mildly elevated blood urea nitrogen and normal creatinine, and what dosing and monitoring are recommended?
What are the latest guidelines for managing bone metabolism, including recommendations for calcium, vitamin D, and pharmacologic therapy?
Is an AST (aspartate aminotransferase) level of 21 U/L normal, and does it require any further evaluation?
How should Invega (paliperidone) be initiated and titrated in a patient with normal creatinine but mildly elevated BUN, and what monitoring and safety considerations are required?
What is the appropriate acute management of aggression in a methamphetamine‑addicted patient with bipolar disorder?
Could the patient’s elevated C‑reactive protein, leukocytosis, and neutrophilia, along with new blood cultures, indicate an initial bacteremia that became intermittent after a negative viral PCR, explaining a day without fever followed by recurrence, and what is the likely source of the bacteremia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.